ALGS is currently covered by 3 analysts with an average price target of $30. This is a potential upside of $28.78 (2359.02%) from yesterday's end of day stock price of $1.22.
Aligos Therapeutics's activity chart (see below) currently has 32 price targets and 40 ratings on display. The stock rating distribution of ALGS is 100% BUY.
Analysts' price targets on this stock were met 20.11% of the time, taking 44.33 days on average.
Highest price target for ALGS is $50, Lowest price target is $20, average price target is $30.
Most recent stock forecast was given by STEVEN SEEDHOUSE from CANTOR FITZGERALD on 29-May-2026. First documented stock forecast 09-Nov-2020.
Currently out of the existing stock ratings of ALGS, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-May-2026
$20
$18.78 (1539.34%)
$20
5 months 23 days ago
(29-May-2026)
0/2 (0%)
$14.3 (250.88%)
Buy Since 22-Jan-2026
$50
$48.78 (3998.36%)
7 months 4 days ago
(17-Apr-2026)
0/3 (0%)
$43.32 (648.50%)
Buy Since 06-Jan-2026
$20
$18.78 (1539.34%)
$75
10 months 14 days ago
(06-Jan-2026)
2/5 (40%)
$10.35 (107.25%)
22
Buy Since 12-Mar-2025
$50
1 years 3 months 3 days ago
(18-Aug-2025)
0/2 (0%)
$41.23 (470.13%)
Buy Since 17-May-2024
$7
2 years 1 months 28 days ago
(24-Sep-2024)
3/5 (60%)
$-5.6 (-44.44%)
119
What is ALGS (Aligos Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ALGS (Aligos Therapeutics)?
Which analyst has the lowest performance score on ALGS (Aligos Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ALGS (Aligos Therapeutics)?
Which analyst is the currently most bullish on ALGS (Aligos Therapeutics)?
Which analyst is the currently most reserved on ALGS (Aligos Therapeutics)?